AngioDynamics
ANGOAngioDynamics is a medical technology company that designs, manufactures, and sells minimally invasive medical devices for the treatment of cardiovascular disease and cancer.
Earnings
Next report
Oct 1, 2026 (in 2 months)Valuation & ratios
Segments
By product
Competitors
By market cap
By revenue growth
Profile
AngioDynamics is a medical technology company that designs, manufactures, and sells minimally invasive medical devices for the treatment of cardiovascular disease and cancer. The company focuses on improving patient outcomes through innovative research and development in vascular access, peripheral vascular disease, and oncology ablation. Its value proposition centers on providing clinicians with high-quality, cost-effective alternatives to traditional surgical procedures.
A diversified player in niche interventional markets, competing through a mix of proprietary high-tech ablation platforms and a broad portfolio of standard interventional supplies.
FAQ
- What is AngioDynamics's market cap?
- AngioDynamics (ANGO) has a market capitalization of $611.3M and trades on NASDAQ.
- What is AngioDynamics's revenue and profitability?
- AngioDynamics generated $320.2M in trailing twelve-month revenue with a net loss of $36.7M, representing a net margin of -11.5%. Gross margin stands at 54.6%, with free cash flow of $508.0K. These figures are based on the Q2 2026 filing.
- Who are AngioDynamics's competitors?
- AngioDynamics's key competitors include Merit Medical Systems, Inc., Medtronic, Teleflex Medical, and others. These companies compete in similar markets and product categories.
- Who does AngioDynamics partner with?
- AngioDynamics's notable partners include Biomerics, Medline Industries, Inc., Merit Medical Systems, Inc., and others.
- What subsidiaries does AngioDynamics have?
- AngioDynamics's subsidiaries include Eximo Medical, Ltd., RadiaDyne.
- Where is AngioDynamics headquartered?
- AngioDynamics is headquartered in United States of America and employs approximately 815 people. It has been publicly traded since 2004.
